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An antiserum to ADP-ribosylated elongation factor 2 (ADPR-EF-2) from B. acidocaldari~s was raised in rabbits using stained, homogenized, 
ADPR-EF-2.containing slic~s from SDS-geI.~ as a source of antigen. Elongation factor 2 (EF-2) from S. acidocaldarius was cloned in E. colt and 
the expressed gong product was used in order to adsorb all anti-EF-2 antibodie, which do not contain the ADP.ribosyl group within their epitopes, 
as E. coR is unable to synthesize the ADP-ribosyl aceeptor diphthamide. T e re aining antibodies were specific to ADP-ribosylated EF-2 from 
Thermoplasma acidopht&m, $. acidocaldarlus nd Oesulfurococcus mncosus. ADP-ribosylated EF-2 from eukaryotic sources also rcact~ with the 
adsorbed antiserum as shown for EF.2 isolated from the killi-fish C),nolebias whitei, the meuse species BALB/e and Han/Wistar rats. The adsorbed 
anti~.crum did not cross-react wi h ADP.ribosylated actin or rho protein or with FAD-containing o-amino acid oxidase. 
Antiserum; Elongation factor 2; ADP-ribosylation; Sulfo&bua' cidocaldarhts 
1. INTRODUCTION 
Elongation factor 2 from eukaryotes and 
archaebacteria is specifically ADP-r ibosylated by diph- 
theria toxin and Pseudomonas toxin A [1,2]. In both 
kingdoms diphthamide, a modified hlstidine, is the spe- 
cific aceeptor of  the ADP-r ibosyl  group, but only in 
eukaryotic cells ADP-ribosyl transferases have been 
found [3,4] which transfer the ADP-r ibose moiety from 
NAD to EF-2. This reaction always results in a block 
of protein synthesis [3,5]. Since only part of the EF-2 is 
ADP-r ibosylated in vivo and the ADP-r ibosyl-EF-2 
(ADPR-EF-2)  had a short half-life [3] it is possible that 
the endogeneous transt~:rase r gulates protein synthesis 
at the level of  elongation. But the physiological condi- 
tions that induce or repress ADP-r ibosylat ion are not 
well understood, although it has been shown that the 
amount  of  ADP-r ibosylatable EF-2 varies in cultured 
cells during the cell cycle [6], during aging [7] and at low 
serum concentration [3]. 
A rabbit  anti-(baby hamster kidney ADPR-EF-2)  an- 
tiserum has been used to immunoprecipitate 
[a'~P]ADPR-EF-2 from various cell types [4] but it 
crossreacted with a lot of other proteins making the 
interpretation o f  the results difficult. We now have suc- 
ceeded to raise an antiserum to ADPR-EF-2  from S. 
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aeidocaldarius in rabbits and to render it specific by 
adsorbtion with recombinant $. acidocaldarius EF-2 ex- 
pressed in E. colt [8,9]. This EF-2 is free ofd iphthamide 
which cannot be built in E. colt; therefore, it is not 
ADP-r ibosylatable by diphtheria toxin. 
2. MATERIALS  AND METHODS 
2.1. Preparation of ADP-ribasylated EF.2 and intnnu~tzation of rabbits 
ADP-ribosylated isoform 1 (pl = 6.2) of EF-2 from S. actdacaldar- 
ius was prepared by ammonium sulfate pr~ipitation, gel filtration on 
Sephadex (3.200 and preparative isoel~tric focusing before and fter 
ADP-ribosylation with diphtheria toxin (Siegmund at~d Klink, unpul:- 
lished), Minor impurities of the ADPR-EF-2 preparation were re- 
moved by preparative SDS-PAGE in slab gels(3 x 200 × 200 ram). 
The Coomassie-stained EF-2 band w s cut out and chilled into ~mall 
pieces which were washed three times with 0.9%Natl, by stirring for 
10 rain. Finally, the gel pieces were minced by a Potter h mogeniz.cr 
to become small enough to be passed through a 22-gauge needl . The 
gel homogenate was washed with 0.9% NaCl unzil the pH of the 
supernatant was raised above 4.0. The gel was stored at -700C in 
portions containing 100 ,ug of ADPR-EF-2. Immediately before im- 
munization, one portion was washed three times with phosphate buff- 
ered saline (PBS) and suspended in PBS. 0,5 ml sus~asion were 
injected into the hind leg~ of the rabbit~ nearby the popliteale lymph 
nodes. The rest was injected intradermally in multiple sites of the 
backs. Six weeks later, the animals were boostered accordingly and 
bled after ten days in two-day intervals for serum collection, until 
slaughtering after another 10 days. 
2.2. Preparation f recombinant EF-2 and adsorbtion of autiserum 
Plasmid pEXg-encoded $. aeidocaldarius EF-2 (rEF-2) was pre- 
pared from E. cali JM 109 cell extracts as dc~:ril~d [9]. The purified 
rEF-2 was bound to CNBr-aetivated Sepharos~ (Pharmacia-LKB) 
accordingly to the instructions of the manufacturer. The antiserum 
was diluted 5-fold with 50 mM Trls.HCI, pH 7.5, containing 150 mM 
NaC; and 0.05% Tv,-een 20. I0 ml of the di!u'a~! -',n!~rm, n.. we~ 
adsorbed by 160/.tg of rEF-2-Sepharose byslowly rotating the suspen- 
sion for 2 h. 
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2.3, Preparation and isoelecitric fac:tsing of EF-2 from mr liver 
EF-2 from rat liver was partially pulified by ultracentrifugation and 
DEAE-eellulosc hromatography as described [10], 10 ml of elua*.e 
from DEAE-ceilulme, containing about 300`ag of EF-2, were dialyzed 
against 20 mM Tris-HCl, pH 7.5, 5 mM mereaptoethanol, 1 raM 
EDTA, 0.1 mM PMSF, The dialysate was mixed with 40 B wet IEF- 
Sephadex (Pharmaeia), 3,5 ml ampholyte pH 4-9, 30 mg DTT and 
double-distilled water to get a smoothable slurry. Flat bed isoelectric 
focusing was performed using ampholyte diluted 1:15 as electrode 
solutions until 8,000 V.h were achieved, 
2.4. Preparation of other elongation factor*' and sate'co f  enzyn)es 
EF-2 from Thermoplasma acMophilum and Desulfurococcus mu. 
cosus were partially purified as described for T, acidophtlum [10]. EF-2 
from mou~e liver was isolated as follows. 3.5 g ofmou~e river (BALB/ 
c) were homogenized in 16.5 ml of 100 mM Tris, 50 mM DTT, 1 mM 
EDTA, 25 #8/ml DNas¢ 1 (r~oehringer), 28#g/ml RNase (Boehringer) 
and 0.1 mM PMSF by two strokes with an Elvehjem homogenizer at
30O rpm. Cell debris was removed by centrifugation for 15 rain at 
30,000 x g. The supernatant protein was precipitated with ammonium 
sulfate at ?0% saturation. After eentrifu~tion, the pellet was washed 
with 55% ammonium sulfate in 50 mM Tris-HCl, pH 8.:5, S mM DTT, 
1 mM EDTA, 0,1 mM PMSF and dissolved in the same buffer, 
ADP-ribosylation of the different EF-2 preparations was performed 
by incubation for 10 rain with 100 #8/ml of diphtheria toxin and 10 
,aM NAD, Fish EF-2 i'rom Cynoleblas )vhitet was prepared according 
to Ludwig et al. (unpublished), 
o-Amino acid oxidase EC 1.4.3.3 from porcine kidney was obtained 
from Sigma (Deisenhofen) and xanthine oxidase EC 1.1.3.22 from cow 
milk was a product from Boehringer (Mannheim), ADP-ribos2clated 
actin and the protein were a generous gift of K. Aktories (Homburg/ 
Soar), 
2.4, Enzyme.linked hnmunosorbent assay attd Western blot 
ELISA was perfonrt,.-~:l in polystyrol microplates, Western blots on 
nitrocellulose, For blocking and washing steps, a buffer containing 50 
mM Tris.HCl, pH 7.5, 150 mM NaCl and 0,05% Tween 20 was used, 
Anti-(rabbit lgG) peroxidase conjugate (Sigma, Deisenhofen) was 
used as the second antibody. Colour was developed f rom o-phenylene- 
diamine in ELISA or 4-ohloro-l-naphthol in blot applications. 
3. RESULTS AND DISCUSSION 
Di rect  immunizat ion  o f  rabb i ts  w i th  Coomass ie -  
s ta ined,  ADPR-EF-2  conta in ing  el slices was chosen  
kOa 
97.4- 
%- . . . .  
adsorbed 
ant iserum 
o b c d e 
monoctonot 
ant ibody 
" L ~ t ~ "  .. 
f g h i k 
A 
...... " ......... '~:C,':if..~.k:i:.!.%'.i.:~ : .%~.::/:'.~.!TTJ~." .. : :.....:..,.. % ": ;,,:';~::.i:,j:!.!.'::i:,!.!.!~ 
:.',, ~t>~,~?~;~,,! ; ' ;~.~,,~i ,~¢~.~,.¢~..~.. .~. . ; .  . .- • .~ .~ .~;~.~. ' r .~-~. ' . . v~ 
. . . .  - ~ - " ~ - ~ i  ~:'~'; "" ~:"~" ':~:'~* '~'~-:"-"~'"':!4"~':~ 
• ,  ~. ~ . . . .~ . . , . :  . . . . .  . - .<? . - ? .~t~d~i~. t ,~ .  -~.  . ~'~'~'~ <-  
• .~ .  ~;  '. • .,¢-';'..t'.,..~'.~q"~. "
i ~. ,~ . . l~  ~ , ' . . : ;  q" -'~: .~'-';~/:' ,~ 
;~ ~ ~  ?~ . . . .  ~..'.g#~ f. {!~.;t: .!~.... :: .:: .. L~.....~;~.~;~....?: '-.~ :~,c:~,; ~&b:.~ ~ ;~'< ~~'-'"~' .'.. : . " ':.~ ..~:.'~x!+,.,' 
• . : i ~ - ~ , :  i.;' :".!": ,"/. '~; "t-~,?~":~.: 
• .... . :~. ~ , ' . - ~ : ~ . - . ~ . . . . . .  ,:, , ~ . ! ,%:  :.. 
. " . ' . .  ~ " ~ ~ 3 ~ : ' : . i  i~..;. ,. " . .  . . .. " : . . : :~ :  
b c d e f g h 
~.,~ ...~4<~.~ 
B 
• . .~t.-  ' . 
~,!-;.~:....;. 
";.!.~:',.,..:'i!i. .. • 
. .c; : .  r..., 
; L, 
Fig, 1. Test on cross-reactivity of adsorh."d anti-(ADPR-EF-2)antiserum in comparison with a monoQlonal nti-(5, acMocaldariua EF-2) antibody. 
(A) Immunostained blot after SDS-PAGE, (B) Additionally staining of protein by Ponceau S. Lanes: (a,f) ADPR-EF-2 from S. acidocaldariua, 
(b,g) EF-2 from S. acidocaldar~us, (¢ h) actin from rabbit skeletal muscle, (d,i) ADP-ribosylated actin, (e,k) xanthine oxidase. 
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Table 1 
Titer of anti-(ADPR-EF-2) antiserum before and after adsorption 
with recombinant S. actdocaMarius EF-2 from E. col? 
Antigen in ELISA Titer bel'or¢ Titer after 
adsorption adsorption 
Recombinant EF-2 440 2 x 10 -9 
EF-2 from S. acidocaldarius 730 3.8 
ADPR-EF-2 320 20 
'Titer is defined as the dilution producing OD = 1.0 in ELISA after 
incubation for 30 rain at 300 rpm on a Titertek mieroplate shaker 
(Flow Laboratories). 
because of the considerably lower amount of antigen 
needed for immune stimulation [11]. Addition of 
Freund's adjuvant was unnecessary, asthe antigen was 
diffusing slowly out of the gel pieces which resulted in 
a depot effect without inducing an inflammation like it 
is caused by the complete adjuvant. Therefore, this pro- 
cedure reduced the pain which the animals could suffer 
from immunization. 
The adsorbtion procedure of the antiserum with re- 
combinant S. acidocaldarius EF-2 (rEF-2) resulted in an 
about 10~"-fold reduction of the antiserum titer for rEF- 
2 compared to an only [ 6-fold reduction of the titer for 
ADPR-EF-2 and a 190-fold reduction for EF-2 isolated 
from S. acMocaldarius (Table I). The considerable lower 
reduction of the titer for native EF-2 might be due to 
trace amounts of in rive ADP-ribosylated EF-2 in the 
preparation or to the fact that native EF-2 contains 
diphthamide which is lacking in rEF-2. However, Fig. 
1, lanes a and b, show that the adsorbed antiserum was 
specific to the ADP-ribosylated form of $. acidocalda- 
rius elongation factor 2 while a monoclonal antibody to 
EF-2 from $. acidocaldarius (which was kindly provided 
by K. Lemkemeier) detected both forms of the factor 
(lanes f and g). No cross-reaction was observed with 
rabbit skeletal muscle actin ADP-ribosylated by Clos- 
tridium perfringens iota toxin (Fig. 1, lanes d and i) or 
with the flavoprotein xanthine oxidase (lanes e and k) 
in either case, using the antiserum specific to ADPR- 
EF-2 (lanes a-e) or the monoclonai antibody to EF-2 
from S. ctcidocaldarius (lanes f-k). Similarly, rho protein 
ADP-ribosylated by Chlostridium botulinum ADP-ri- 
bosyl transferase C3 [12] did not react with the antise- 
rum (data not shown). On the other hand, Fig. 2 shows 
that the adsorbed antiserum specifically detected 
ADPR-EF-2 on Western blots of partially purified EF- 
2 from various archaebacterial as well as eukaryotie 
sources. With the exception of the fish extract, a slight 
reaction of the antiserum with the EF-2 band in the 
samples which were not treated by diphtheria toxin a d 
NAD, may indicate that the factors were in vivo ADP- 
ribosylated to some extent. Besides the EF-2 band at 85 
kDa, a smaller ADP.ribosylatable EF-2 fragment of 80 
kDa was detected in the extracts from the 
archaebacteria. In contrast o these observations, Ibr 
eukaryotes only the extract from mouse liver showed an 
ADP-ribosylated fragment of EF-2 or another small 
ADP-ribosylated protein with a molecular weight of 
about 40 kDa (Fig. 2, lanes I and m). 
Meyer and Hilz [13] have produced an anti-(ADP- 
ribose) antiserum which did react with ADP-ribosylated 
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Fi~. 9. Specificity of adsorbed anti-(ADPR..EF.2) antiserum to partially purified elongation factor 2 from different sources, lmmano~taincd blot 
after SDS-PAGE of in vitro ADP-ribosylated (.~) and not ADP-ribosylated (-)  EF-2: (a,b) T. acidophihan (180 ng each), (c,d) S. aciducatdarfits 
(180 ng), (e,f) D. mucosus (90 ng), (g,h) Han/Wist~r rat liver (110 as), (i,k) Cynolebias whitei (10 as), (I,m) mouse liver (BALB/¢) (4 ng). 
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Fig. 3. Preparative isoelec~rie focusing of EF-2 from rat liver. ELISA 
with anti-(ADPR-EF-2) antiserum before (o) and after (o)in vitro 
ADP-ribosylation of the EF-2 contained in each fraction, (-.--) 
proteln. 
tion) as well as with FAD, ADPR-EF-2  and mono- 
ADP-ribosylated nuclear proteins [13]. These authors 
also reported on difficulties in immunization of rabbits 
wit~a ADP-ribosylated proteins due to phosphodies- 
terase which hydrolyzed the diphosphate group of 
the hapten [14]. They have circumvented this problem 
by synthesis of an ADP[CH.q-ribose serum albumin 
conjugate which was used to raise an antiserum in rab- 
bits. In our experiments, hydrolysis was possibly pre- 
vented by the use of  SDS-gel pieces as the antigen depot. 
On diffusion of the protein to the gel surface, the ADPR 
g'roups might have been presented to the immune cells 
and have stimulated antibody production, betbre they 
have been recognized by the hydrolytic enzymes. How- 
ever, in contrast to the anti-(ADP-ribose) antiserum 
produced by Meyer and Hilz [13] which showed a rather 
broad specifity to all kinds of ADP-ribosylated pro- 
teins, our adsorbed antiserum, although raised with 
ADPR-EF-2 from S. acidocaldarius, was specific to 
ADPR-EF-2 from various arehaebacterial and eukar- 
yotic sources. This indicates that some of  the highly 
conserved amino acids within the ADP-ribosylatable 
domain of  EF-2 [8], but at least the ADPR accepter 
diphthamide itself, must have been a part of the anti- 
body inducing epitops, For  comparison, aetin is ADP- 
ribosylated at arginine-177 [1 5] and the the protein at 
an asparagine residue [16]. 
Fig. 3 depicts an application of  the ADPR-EF-2-spe- 
cifie antiserum in the purification of  rat liver elongation 
factor 2. The partially purified rat liver EF-2 which was 
analyzed by immunoblot with the adsorbed antiserum 
(Fig. 2, lanes g and h) was further purified by prepara- 
tive isoelectric focusing. Without ADP-ribosylation of 
the EF-2 in the fractions, three small peaks at pH 5.0, 
5.5 and 6.25 was detected by ELISA. But only the peak 
at pH 6.25 was raised about 5-fold by ADP-ribosylation 
resulting in a peak at pH 6.4 w;_th a broad shoulder at 
pH 6.0 while the peak at pH 5.0 rather was reduced. 
This indicates that the peak at pH 6.25 contained at 
least two ADP-ribosylatable isoforms of EF-2 while the 
peaks at pH 5.0 and 5.5 may have contained trace 
amounts of  in r ive ADP-ribosylated EF-2. 
In summary, we have produced an antiserum specific 
to ADP-ribosylated EF-2 from archaebacteria as well 
as eukaryotes. The existence of some antibodies to un- 
substituted iphthamide in the serum as mentioned 
above seems rather unlikely as the EF-2 used for raising 
the antiserum was almost completely ADP-ribosylated 
and the ribose-phosphate bound to diphthamide cannot 
be removed by phosphodiesterase. Thus, we have ob- 
tained a valuable tool for elucidation of  the role which 
this posttranslational modification might play in regula- 
tion of metabolism. Studies are currently underway to 
identify the physiological conditions of  in vivo ADP- 
ribosylation of  EF-2 from S. acidocaldarius. 
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